MedPath

PFIZER AUSTRALIA PTY LTD

PFIZER AUSTRALIA PTY LTD logo
🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

490

TGA:470
NMPA:20

Drug Approvals

Methotrexate Injection

Product Name
美素生
Approval Number
国药准字HJ20090596
Approval Date
Nov 7, 2024
NMPA

Methotrexate Injection

Product Name
美素生
Approval Number
国药准字HJ20090597
Approval Date
Nov 7, 2024
NMPA

Paclitaxel Injection

Product Name
安素泰
Approval Number
国药准字HJ20150351
Approval Date
Nov 4, 2024
NMPA

Paclitaxel Injection

Product Name
安素泰
Approval Number
国药准字HJ20150350
Approval Date
Nov 4, 2024
NMPA

Methotrexate Injection

Product Name
美素生
Approval Number
国药准字HJ20245005
Approval Date
Sep 24, 2024
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20140205
Approval Date
Jul 28, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20140206
Approval Date
Jul 28, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字HJ20140207
Approval Date
Jul 28, 2023
NMPA

Isavuconazonium Sulfate for Injection

Product Name
注射用硫酸艾沙康唑
Approval Number
国药准字HJ20220054
Approval Date
Jun 16, 2022
NMPA

Isavuconazonium Sulfate Capsules

Product Name
康新博
Approval Number
国药准字HJ20210079
Approval Date
Dec 14, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath